Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic Escherichia coli among children in the United States

ABSTRACT Escherichia coli is the most common cause of urinary tract infections (UTIs) in children, and yet the underlying mechanisms of virulence and antibiotic resistance and the overall population structure of the species is poorly understood within this age group. To investigate whether uropathogenic E. coli (UPEC) from children who developed pyelonephritis carried specific genetic markers, we generated whole-genome sequence data for 96 isolates from children with UTIs. This included 57 isolates from children with either radiologically confirmed pyelonephritis or cystitis and 27 isolates belonging to the well-known multidrug-resistant sequence type ST131, selected to investigate their population structure and antibiotic resistance characteristics. We observed a UPEC population structure that is similar to those reported in adults. In comparison with prior investigations, we found that the full pap operon was more common among UPEC from pediatric cases of pyelonephritis. Further, in contrast with recent reports that the P-fimbriae adhesin-encoding papGII allele is substantially more prevalent in invasive UPEC from adults, we found papGII was common to both invasive and non-invasive UPEC from children. Among the set of ST131 isolates from children with UTIs, we found antibiotic resistance was correlated with known genetic markers of resistance, as in adults. Unexpectedly, we observed that fimH30, an allele of the fimbrial gene fimH often used as a proxy to type ST131 isolates into the most drug-resistant subclade C, was carried by some of the subclade A and subclade B isolates, suggesting that the fimH30 allele could confer a selective advantage for UPEC. IMPORTANCE Urinary tract infections (UTIs), which are most often caused by Escherichia coli, are not well studied in children. Here, we examine genetic characteristics that differentiate UTI-causing bacteria in children that either remain localized to the bladder or are involved in more serious kidney infections. We also examine patterns of antibiotic resistance among strains from children that are part of E. coli sequence type 131, a group of bacteria that commonly cause UTIs and are known to have high levels of drug resistance. This work provides new insight into the virulence and antibiotic resistance characteristics of the bacteria that cause UTIs in children. Urinary tract infections (UTIs), which are most often caused by Escherichia coli, are not well studied in children. Here, we examine genetic characteristics that differentiate UTI-causing bacteria in children that either remain localized to the bladder or are involved in more serious kidney infections. We also examine patterns of antibiotic resistance among strains from children that are part of E. coli sequence type 131, a group of bacteria that commonly cause UTIs and are known to have high levels of drug resistance. This work provides new insight into the virulence and antibiotic resistance characteristics of the bacteria that cause UTIs in children.

[1]  B. Heras,et al.  Conserved FimH mutations in the global Escherichia coli ST131 multi-drug resistant lineage weaken interdomain interactions and alter adhesin function , 2022, Computational and structural biotechnology journal.

[2]  M. Schembri,et al.  Gut–bladder axis in recurrent UTI , 2022, Nature Microbiology.

[3]  B. Walker,et al.  Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women , 2022, Nature Microbiology.

[4]  H. Goossens,et al.  Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages , 2020, Nature Communications.

[5]  Peter L. Freddolino,et al.  A Thermosensitive, Phase-Variable Epigenetic Switch: pap Revisited , 2020, Microbiology and Molecular Biology Reviews.

[6]  H. Rockette,et al.  Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial , 2020, Pediatric Nephrology.

[7]  G. Tseng,et al.  Biomarkers that differentiate false positive urinalyses from true urinary tract infection , 2019, Pediatric Nephrology.

[8]  U. Dobrindt,et al.  Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae , 2019, PLoS pathogens.

[9]  Jian Yang,et al.  VFDB 2019: a comparative pathogenomic platform with an interactive web interface , 2018, Nucleic Acids Res..

[10]  Keith A Jolley,et al.  Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications , 2018, Wellcome open research.

[11]  S. Konda,et al.  Community origins and regional differences highlight risk of plasmid-mediated fluoroquinolone resistant Enterobacteriaceae infections in children , 2018, bioRxiv.

[12]  Jukka Corander,et al.  pyseer: a comprehensive tool for microbial pangenome-wide association studies , 2018, bioRxiv.

[13]  O. Lund,et al.  Development of a Web Tool for Escherichia coli Subtyping Based on fimH Alleles , 2017, Journal of Clinical Microbiology.

[14]  G. Peirano,et al.  Rapid Identification of Different Escherichia coli Sequence Type 131 Clades , 2017, Antimicrobial Agents and Chemotherapy.

[15]  Wen-Chi Chou,et al.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections , 2017, Science Translational Medicine.

[16]  Jacqueline A. Keane,et al.  ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads , 2017, bioRxiv.

[17]  J. Pitout,et al.  Escherichia coli ST131: a multidrug-resistant clone primed for global domination , 2017, F1000Research.

[18]  G. Peirano,et al.  Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene , 2016, Emerging infectious diseases.

[19]  Raymond Lo,et al.  CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database , 2016, Nucleic Acids Res..

[20]  Michael Inouye,et al.  In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages , 2016, Microbial genomics.

[21]  S. Conlan,et al.  Horizontal Transfer of Carbapenemase-Encoding Plasmids and Comparison with Hospital Epidemiology Data , 2016, Antimicrobial Agents and Chemotherapy.

[22]  S. Salzberg,et al.  Centrifuge: rapid and sensitive classification of metagenomic sequences , 2016, bioRxiv.

[23]  H. J. Kolmos,et al.  Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions. , 2016, The Journal of infectious diseases.

[24]  H. Mobley,et al.  Virulence and Fitness Determinants of Uropathogenic Escherichia coli , 2015, Microbiology spectrum.

[25]  Nicholas A. Bokulich,et al.  Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment , 2015, Nature Communications.

[26]  Daniel J. Wilson,et al.  ClonalFrameML: Efficient Inference of Recombination in Whole Bacterial Genomes , 2015, PLoS Comput. Biol..

[27]  Christina A. Cuomo,et al.  Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement , 2014, PloS one.

[28]  C. Forrest,et al.  Association of antibiotics in infancy with early childhood obesity. , 2014, JAMA pediatrics.

[29]  J. Wain,et al.  Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream Infections , 2014, Journal of Clinical Microbiology.

[30]  Justin Zobel,et al.  SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014, bioRxiv.

[31]  Xavier Bertrand,et al.  Escherichia coli ST131, an Intriguing Clonal Group , 2014, Clinical Microbiology Reviews.

[32]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[33]  Nicola K. Petty,et al.  Global dissemination of a multidrug resistant Escherichia coli clone , 2014, Proceedings of the National Academy of Sciences.

[34]  E. Denamur,et al.  Rapid and Specific Detection, Molecular Epidemiology, and Experimental Virulence of the O16 Subgroup within Escherichia coli Sequence Type 131 , 2014, Journal of Clinical Microbiology.

[35]  Maliha Aziz,et al.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. , 2013, The Journal of infectious diseases.

[36]  L. Price,et al.  Role of Homologous Recombination in Adaptive Diversification of Extraintestinal Escherichia coli , 2012, Journal of bacteriology.

[37]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[38]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  B. Dhakal,et al.  The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. , 2012, Cell host & microbe.

[40]  D. Heckerman,et al.  FaST linear mixed models for genome-wide association studies , 2011, Nature Methods.

[41]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[42]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[43]  Scott J. Hultgren,et al.  Quantitative Metabolomics Reveals an Epigenetic Blueprint for Iron Acquisition in Uropathogenic Escherichia coli , 2009, PLoS pathogens.

[44]  H. Mobley,et al.  Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection , 2009, Molecular microbiology.

[45]  H. Mobley,et al.  Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. , 2007, Kidney international.

[46]  Alexandros Stamatakis,et al.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models , 2006, Bioinform..

[47]  H. Mobley,et al.  Protease Activity, Secretion, Cell Entry, Cytotoxicity, and Cellular Targets of Secreted Autotransporter Toxin of Uropathogenic Escherichia coli , 2006, Infection and Immunity.

[48]  R. Benz,et al.  Both alpha-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536. , 2006, Microbes and infection.

[49]  C. Svanborg,et al.  Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. , 2005, International journal of medical microbiology : IJMM.

[50]  D. Rasko,et al.  Autotransporter Genes pic and tsh Are Associated with Escherichia coli Strains That Cause Acute Pyelonephritis and Are Expressed during Urinary Tract Infection , 2004, Infection and Immunity.

[51]  D. Low,et al.  Self-perpetuating epigenetic pili switches in bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Harry L. T. Mobley,et al.  Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells , 2002, Infection and Immunity.

[53]  G. Waksman,et al.  Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor , 2001, Cell.

[54]  S. Hakomori,et al.  The Globoseries Glycosphingolipid Sialosyl Galactosyl Globoside Is Found in Urinary Tract Tissues and Is a Preferred Binding Receptor In Vitro for Uropathogenic Escherichia coli Expressing pap-Encoded Adhesins , 1998, Infection and Immunity.

[55]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Normark,et al.  The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Normark,et al.  Saccharide orientation at the cell surface affects glycolipid receptor function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. Blyn,et al.  Phase‐variation of pyelonephritis‐associated pili in Escherichia coli: evidence for transcriptional regulation. , 1989, The EMBO journal.

[59]  S. Falkow,et al.  Contribution of Adhesion to Bacterial Persistence in the Mouse Urinary Tract , 1983, Infection and immunity.

[60]  R. Möllby,et al.  OCCURRENCE OF P-FIMBRIATED ESCHERICHIA COLI IN URINARY TRACT INFECTIONS , 1981, The Lancet.

[61]  H. Hansson,et al.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells , 1978, Infection and immunity.

[62]  G. Peirano,et al.  Escherichia coli ST131: The quintessential example of an international multiresistant high-risk clone. , 2015, Advances in applied microbiology.

[63]  D. Paterson,et al.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. , 2011, The Journal of antimicrobial chemotherapy.